DK3277818T3 - Brug af vitaminer og vitaminstofskiftegener og -proteiner til produktion af rekombinant protein i pattedyrsceller - Google Patents

Brug af vitaminer og vitaminstofskiftegener og -proteiner til produktion af rekombinant protein i pattedyrsceller Download PDF

Info

Publication number
DK3277818T3
DK3277818T3 DK16719778.9T DK16719778T DK3277818T3 DK 3277818 T3 DK3277818 T3 DK 3277818T3 DK 16719778 T DK16719778 T DK 16719778T DK 3277818 T3 DK3277818 T3 DK 3277818T3
Authority
DK
Denmark
Prior art keywords
vitamines
proteins
mammalian cells
recombinant protein
producing recombinant
Prior art date
Application number
DK16719778.9T
Other languages
English (en)
Inventor
Nicolas Mermod
Lucille Pourcel
Pierre-Alain Girod
Fourn Valérie Le
Original Assignee
Selexis Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Selexis Sa filed Critical Selexis Sa
Application granted granted Critical
Publication of DK3277818T3 publication Critical patent/DK3277818T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67General methods for enhancing the expression
    • C12N15/68Stabilisation of the vector
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67General methods for enhancing the expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67General methods for enhancing the expression
    • C12N15/69Increasing the copy number of the vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/001Vector systems having a special element relevant for transcription controllable enhancer/promoter combination

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK16719778.9T 2015-04-03 2016-04-01 Brug af vitaminer og vitaminstofskiftegener og -proteiner til produktion af rekombinant protein i pattedyrsceller DK3277818T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562142516P 2015-04-03 2015-04-03
PCT/EP2016/057228 WO2016156574A1 (en) 2015-04-03 2016-04-01 Use of vitamins and vitamin metabolic genes and proteins for recombinant protein production in mammalian cells

Publications (1)

Publication Number Publication Date
DK3277818T3 true DK3277818T3 (da) 2020-02-24

Family

ID=55862725

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16719778.9T DK3277818T3 (da) 2015-04-03 2016-04-01 Brug af vitaminer og vitaminstofskiftegener og -proteiner til produktion af rekombinant protein i pattedyrsceller

Country Status (19)

Country Link
US (1) US20180066268A1 (da)
EP (1) EP3277818B1 (da)
JP (1) JP6767991B2 (da)
KR (1) KR102622657B1 (da)
CN (1) CN107624133A (da)
AU (1) AU2016240211B2 (da)
CA (1) CA2976723A1 (da)
DK (1) DK3277818T3 (da)
ES (1) ES2773529T3 (da)
HK (1) HK1244029A1 (da)
HU (1) HUE047656T2 (da)
IL (1) IL254799B (da)
LT (1) LT3277818T (da)
PL (1) PL3277818T3 (da)
PT (1) PT3277818T (da)
RU (1) RU2736705C2 (da)
SG (1) SG11201706617SA (da)
SI (1) SI3277818T1 (da)
WO (1) WO2016156574A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019004293A1 (ja) * 2017-06-27 2019-01-03 味の素株式会社 リボフラビン誘導体含有培地
CN113348248A (zh) 2018-10-24 2021-09-03 思兰克斯有限公司 表达系统、重组细胞及其用途
EP3896168A4 (en) * 2018-12-11 2022-03-02 FUJIFILM Corporation ANIMAL CELLS, METHODS OF PRODUCTION OF ANIMAL CELLS AND METHODS OF PRODUCTION OF TARGET PROTEIN

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2310686C2 (ru) * 1999-06-25 2007-11-20 Басф Акциенгезелльшафт Гены corynebacterium glutamicum, кодирующие белки, участвующие в метаболизме углерода и продуцировании энергии
US20030091640A1 (en) * 2001-02-08 2003-05-15 Srinivasan Ramanathan Enhanced oral and transcompartmental delivery of therapeutic or diagnostic agents
BRPI0821401A2 (pt) * 2007-12-21 2014-10-14 Novartis Ag Compostos orgânicos
ES2440321T3 (es) * 2009-02-27 2014-01-28 Novartis Ag Métodos para seleccionar células eucarióticas que expresan una proteína heteróloga
MX2011009025A (es) * 2009-02-27 2011-09-28 Novartis Ag Sistema de vector de expresion que comprende dos marcadores de seleccion.

Also Published As

Publication number Publication date
IL254799A0 (en) 2017-12-31
PT3277818T (pt) 2020-03-03
CN107624133A (zh) 2018-01-23
PL3277818T3 (pl) 2020-06-15
CA2976723A1 (en) 2016-10-06
RU2017128122A3 (da) 2020-03-19
EP3277818B1 (en) 2020-01-08
SI3277818T1 (sl) 2020-04-30
RU2736705C2 (ru) 2020-11-19
IL254799B (en) 2021-04-29
US20180066268A1 (en) 2018-03-08
JP2018509904A (ja) 2018-04-12
HUE047656T2 (hu) 2020-05-28
ES2773529T3 (es) 2020-07-13
RU2017128122A (ru) 2019-05-06
KR102622657B1 (ko) 2024-01-10
AU2016240211A1 (en) 2017-08-10
LT3277818T (lt) 2020-02-25
KR20170133327A (ko) 2017-12-05
AU2016240211B2 (en) 2022-03-31
JP6767991B2 (ja) 2020-10-14
EP3277818A1 (en) 2018-02-07
SG11201706617SA (en) 2017-09-28
WO2016156574A1 (en) 2016-10-06
HK1244029A1 (zh) 2018-07-27

Similar Documents

Publication Publication Date Title
HRP20181989T1 (hr) Sredstva za i postupci određivanja biološke aktivnosti neurotoksičnih polipeptida u stanicama
HK1248162A1 (zh) 因數ix融合蛋白以及其製備及使用方法
CY1121217T1 (el) Μεθοδοι για συγκομιδη καλλιεργειων κυτταρου θηλαστικων
CY1125392T1 (el) Συνθεσεις και μεθοδοι γλυζυλιωσης πρωτεϊνων
DK3310805T3 (da) Pd-1-cd28-fusionsproteiner og anvendelse deraf i medicin
DK3461893T3 (da) Fremstilling af biblioteker af proteinvarianter eksprimereret i eukaryotiske celler og anvendelse til udvælgelse af bindingsmolekyler
DK2858664T3 (da) Hgh-xten-fusionsprotein og anvendelse deraf i behandling af væksthormonmangel
DK2986124T3 (da) Fedtreduceret fedtstof og anvendelse deraf i bagværk og konditorvarer
MX2017014397A (es) Anticuerpos anti-receptor neonatal de fragmento cristalizable(fcrn).
EA201791918A1 (ru) Модификация белков клеток-хозяев
DK3697804T3 (da) REKOMBINANT EKSPRESSION AF PCV2b-ORF2-PROTEIN I INSEKTCELLER
DK3431507T3 (da) Fusionsprotein omfattende nervevækstfaktor og fremstillingsfremgangsmåde og anvendelse deraf
DK3313864T3 (da) Rekombinante virusvektorer indeholdende prrsv minor protein og fremgangsmåder til fremstilling og anvendelse deraf
HK1253900A1 (zh) 用於蛋白生產的改進的真核細胞及其製備方法
DK3277818T3 (da) Brug af vitaminer og vitaminstofskiftegener og -proteiner til produktion af rekombinant protein i pattedyrsceller
IL268234A (en) Factor ix fusion proteins and methods of making and using same
HK1219979A1 (zh) '- 用於植物的重組蛋白的過度表達的具有最佳的 '- 前導區功能的人工 序列和産生植物的重組蛋白的方法
AR094875A1 (es) Formulaciones y procedimientos para la producción de proteína recombinante aumentada
IL284803A (en) Methods for the production of multimeric proteins in eukaryotic host cells
SG11201608489VA (en) Enrichment and characterization of human corneal endothelial cells (hcenc) with novel monoclonal antibody
EP3494231A4 (en) METHODS FOR IDENTIFYING NEW PROTEINS AND NEW ANTIGENS IN CANCER CELLS
WO2014169254A3 (en) Therapeutic peptide-expressing cells
CL2015000239A1 (es) Procedimiento de producción de proteínas recombinantes complejas en línea celular de glándula mamaria de cabra; y dicha línea celular.
CO6821887A2 (es) Polipéptido de anticuerpo recombinante anti-cianobasterias, gel del mismo,y método de preparación del mismo
AU2015900198A0 (en) Methods for improving cell yields in cell expansion and cell culture